Conditions:   Fallopian Tube Cancer;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Uterine Sarcoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage III Ovarian Epithelial Cancer;   Stage III Ovarian Germ Cell Tumor;   Stage III Uterine Sarcoma;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Uterine Sarcoma;   Stage IV Vulvar Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer
Interventions:   Radiation: stereotactic radiosurgery;   Procedure: quality-of-life assessment
Sponsor:   Case Comprehensive Cancer Center
Recruiting - verified March 2010

Condition:   Endometrial Cancer
Intervention:  
Sponsors:   Queensland Centre for Gynaecological Cancer;   Greenslopes Private Hospital;   University of Queensland;   Sullivan and Nicolaides Pathology
Recruiting - verified February 2010

Condition:   Endometrial Hyperplasia
Interventions:   Drug: Provera (medroxyprogesterone/progestin);   Drug: Provera (medroxyprogesterone);   Device: Mirena (levonorgestrel)
Sponsors:   University Hospital of North Norway;   Helse Nord;   Norwegian Cancer Society
Recruiting - verified February 2010

Condition:   Polycystic Ovarian Syndrome
Interventions:   Drug: Endometrin (progesterone 100mg vaginal inserts);   Drug: Metformin
Sponsors:   Yale University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010